Physical activity induced protection against breast cancer risk associated with delayed parity-Reference-Cited by-同舟云学术

Physical activity induced protection against breast cancer risk associated with delayed parity

Published:2017-02 Issue: Volume:169 Page:52-58
ISSN:0031-9384
Container-title:Physiology & Behavior
language:en
Short-container-title:Physiology & Behavior

Author:

Sturgeon Kathleen M.,Schweitzer Aaron^ORCID,Leonard John J.,Tobias Deirdre K.,Liu Ying,Cespedes Feliciano Elizabeth,Malik Vasanti S.,Joshi Amit,Rosner Bernard,De Jonghe Bart C.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Experimental and Cognitive Psychology

Reference40 articles.

1. U. S. C. S. W. United States Cancer Statistics: 1999–2012 Incidence and Mortality Web-based Report;Group,2015

2. Cumulative risk of breast cancer to age 70years according to risk factor status: data from the Nurses' Health Study;Colditz;Am. J. Epidemiol.,2000

3. Nurses' health study: log-incidence mathematical model of breast cancer incidence;Rosner;J. Natl. Cancer Inst.,1996

4. Timing of menarche and first full-term birth in relation to breast cancer risk;Li;Am. J. Epidemiol.,2008

5. Puberty in girls of the 21st century;Biro;J. Pediatr. Adolesc. Gynecol.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in physical activity research for breast cancer - A bibliometric analysis of the past ten years;Heliyon;2023-12

2. Tenofovir alone or combined with doxorubicin abrogates DMBA-induced mammary cell carcinoma: An insight into its modulatory impact on oxidative/Notch/apoptotic signaling;Life Sciences;2023-08

3. Physical activity from menarche-to-first pregnancy and risk of breast cancer: the California teachers study;Cancer Causes & Control;2022-08-20

4. Moderate aerobic exercise and probiotic intake on FOXA1 gene expression in non-alcoholic fatty liver animal model: An Experimental Study;Journal of Sports Physiology and Athletic Conditioning;2022-06-19

5. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment;Biomedicine & Pharmacotherapy;2022-01